SKC Joins MAP Group to Capture German Market
Deal News | Nov 13, 2024 | Consultance.eu
The MAP Group, a British pharmaceutical and biotech consultancy, has acquired SKC, a German firm specializing in market access and pricing services. Based in Hannover, SKC is a leading consultancy in Germany, expanding its expertise across pharma, biotech, medtech, and digital health companies in the DACH region. The acquisition supports The MAP Group’s mission to become Europe's top independent pharmaceutical and biotech management consultancy, enhancing their pan-European presence and German market operations. This move follows the Q2 purchase of AxTalis, expanding their regulatory, compliance, and medical affairs advisory in Benelux. Supported by Kester Capital, The MAP Group's buy-and-build strategy aims at consolidating its market strength. Post-acquisition, SKC's founders join The MAP Group's executive leadership team.
Sectors
- Pharmaceutical and Biotechnology Consultancy
- Mergers and Acquisitions
Geography
- Germany – SKC is based in Hannover, Germany, and the acquisition strengthens MAP Group's presence in the German market.
- United Kingdom – The MAP Group, a British consultancy, is expanding its operations across Europe, including Germany.
- Benelux – MAP Group has expanded its regulatory services in the Benelux area through its recent acquisition of AxTalis.
Industry
- Pharmaceutical and Biotechnology Consultancy – The article discusses the acquisition of SKC, a consultancy firm specializing in market access and pricing services in the pharmaceutical and biotech sectors.
- Mergers and Acquisitions – The article details the acquisition of SKC by The MAP Group, highlighting the strategic expansion through M&A activity.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| The MAP Group | Acquiring Company | Company | A British pharmaceutical and biotech consultancy aiming to become Europe's largest independent specialist in the field. |
| SKC | Target Company | Company | A German consultancy specializing in market access and pricing services for the pharma, biotech, and digital health sectors. |
| Kester Capital | Financial Backer | Company | A private equity firm supporting The MAP Group's buy-and-build strategy. |
| Steve Glass | CEO of MAP Group | Person | CEO providing leadership for MAP Group's strategic expansion in Europe. |
| Matthias Schnermark | Founders/Managing Partners of SKC | Person | Joining MAP Group's executive leadership team post-acquisition. |
| Heike Kielhorn-Schnermark | Founders/Managing Partners of SKC | Person | Joining MAP Group's executive leadership team post-acquisition. |